首页 > 市场调查报告书 > 製药

生物製剂分子标靶治疗学

北美抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型、性质、服务和最终用户

市场调查报告书

商品编码

1592592

北美抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型、性质、服务和最终用户

North America Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日期: 2024年09月16日 | 出版商:

The Insight Partners | 英文 94 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美抗体发现市值为129823757万美元，预计到2030年将达到220169241万美元；预计2022年至2030年复合年增长率为6.8%。

增加研发投资推动北美抗体发现市场

抗体（包括单株和多株）在学术、研究和製药机构和组织中得到应用，其中它们用于与药物和生物标记开发以及其他治疗和临床诊断产品开发相关的多种研发活动。中小企业每年都专注于增加研发投入。 2020年4月，美国联邦政府根据《冠状病毒援助、救济和经济安全（CARES）法案》向生物医学高级研究与开发局（BARDA）拨款35亿美元，为製造、生产和采购提供财政支持疫苗、诊断、治疗和小分子活性药物成分(API) 等。此外，製药公司 Bio-Rad 提供 10,000 种抗体以及抗原、试剂和缓衝液，用于开发体外诊断测试。因此，製药公司增加对抗体发现相关研发活动的投资，为各种疾病开发更好的治疗方案，推动抗体发现市场的成长。

北美抗体发现市场概况

北美抗体发现市场分为美国、加拿大和墨西哥。该地区的市场成长取决于癌症盛行率的增加、抗体研究产业的强劲发展以及研发领域的技术进步。根据美国癌症协会的数据，2020 年美国新诊断出约 180 万癌症病例，约 606,520 例与癌症相关的死亡。资金的激增进一步促进了新技术的开发、跨国家和组织的资源和专业知识的汇集，以及对现有抗体治疗方法的研究工作。这使得人们更了解免疫系统，并开发出有效的、有针对性的抗体。此外，增加的资金使科学家能够进行大规模临床试验，这些试验是评估特定抗体有效性所必需的。

北美抗体发现市场收入及 2030 年预测（十亿美元）

北美抗体发现市场细分

北美抗体发现市场按抗体类型、性质、服务、最终用户和国家分类。

根据抗体类型，北美抗体发现市场分为单株抗体、多株抗体等。 2022 年，单株抗体领域占据北美最大的抗体发现市场。

就性质而言，北美抗体发现市场分为人类和人源化、嵌合和鼠类。 2022 年，人类和人源化细分市场占据北美最大的抗体发现市场。

依服务划分，北美抗体发现市场分为噬菌体展示、杂交瘤、基因改造动物、单细胞和酵母展示。 2022 年，噬菌体展示领域占据北美最大的抗体发现市场。

根据最终用户，北美抗体发现市场分为製药和生物技术公司、研究实验室等。 2022 年，製药和生物技术公司领域占据北美最大的抗体发现市场。

根据国家/地区，北美抗体发现市场分为美国、加拿大和墨西哥。 2022 年，美国在北美抗体发现市场份额中占据主导地位。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Bruker Cellular Analysis Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、NanoCellect Biomedical Inc 和 Biocytogen Pharmaceuticals 北京有限公司是其中一些领先公司在北美有限公司发现市场运作。

Antibodies, including monoclonal and polyclonal, find applications in academic, research, and pharmaceutical institutes and organizations, wherein they are used in several R&D activities related to drug and biomarker development, and other therapeutic and clinical diagnostics product development. Small and medium-sized companies focus on raising their R&D investments every year. In April 2020, the US federal government assigned US$ 3.5 billion to the Biomedical Advanced Research and Development Authority (BARDA) under its Coronavirus Aid, Relief, and Economic Security (CARES) Act to provide financial support for the manufacturing, production, and procurement of vaccines, diagnostics, therapeutics, and small molecule active pharmaceutical ingredients (APIs), among others. Further, Bio-Rad, a pharmaceutical company, provides 10,000 antibodies, along with antigens, reagents, and buffers, to develop in vitro diagnostic tests. Therefore, the increasing investments by pharmaceutical companies in research and development activities related to antibody discovery to develop better treatment options for various diseases propels the antibody discovery market growth.

North America Antibody Discovery Market Overview

The North America antibody discovery market is segmented into the US, Canada, and Mexico. Market growth in the region is determined by an increase in the prevalence of cancer, the strong presence of the antibody research industry, and technological advancements in the R&D sector. According to the American Cancer Society, ~1.8 million new cancer cases were diagnosed and ~606,520 deaths related to cancer were recorded in the US in 2020. This bolsters the need for therapeutic antibodies, thereby fueling the antibody discovery market growth. An upsurge in funding further enables the development of new technologies, pooling of resources and expertise across countries and organizations, and conducting research work into existing antibody treatments. This has led to a better understanding of the immune system, and the development of effective and targeted antibodies. Additionally, the increased funding allows scientists to conduct large-scale clinical trials that are mandatory to evaluate the effectiveness of a particular antibody.

North America Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

North America Antibody Discovery Market Segmentation

The North America antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the North America antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest North America antibody discovery market share in 2022.

In terms of nature, the North America antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest North America antibody discovery market share in 2022.

By services, the North America antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest North America antibody discovery market share in 2022.

Based on end user, the North America antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest North America antibody discovery market share in 2022.

Based on country, the North America antibody discovery market is categorized into the US, Canada, and Mexico. The US dominated the North America antibody discovery market share in 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Bruker Cellular Analysis Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, NanoCellect Biomedical Inc, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the North America antibody discovery market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Antibody Discovery Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Investments in Research & Development
- 4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
- 4.2.1 High Cost of Production
4.3 Market Opportunities
- 4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
- 4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - North America Market Analysis

5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. North America Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview
6.2 Monoclonal Antibodies
- 6.2.1 Overview
- 6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
- 6.3.1 Overview
- 6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Antibody Discovery Market Analysis - by Nature

7.1 Overview
7.2 Human and Humanized
- 7.2.1 Overview
- 7.2.2 Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
- 7.3.1 Overview
- 7.3.2 Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
- 7.4.1 Overview
- 7.4.2 Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Antibody Discovery Market Analysis - by Services

8.1 Overview
8.2 Phage Display
- 8.2.1 Overview
- 8.2.2 Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
- 8.3.1 Overview
- 8.3.2 Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
- 8.4.1 Overview
- 8.4.2 Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
- 8.5.1 Overview
- 8.5.2 Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
- 8.6.1 Overview
- 8.6.2 Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Antibody Discovery Market Analysis - by End User

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Antibody Discovery Market - Country Analysis

10.1 North America Market Overview
- 10.1.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 US
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.2 Canada
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User
  - 10.1.1.3 Mexico
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
    - 10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
    - 10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
    - 10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Creative Biolabs Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Evotec SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bruker Cellular Analysis Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioDuro LLC
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Sartorius AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Aragen Life Sciences Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Twist Bioscience Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 NanoCellect Biomedical Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Biocytogen Pharmaceuticals Beijing Co Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 16. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 17. Glossary of Terms, Antibody Discovery Market

List Of Figures

Figure 1. North America Antibody Discovery Market Segmentation, by Country
Figure 2. North America Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. North America Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Growth Strategies in the Antibody Discovery Market